The global HPV testing and Pap test market is anticipated to grow at a significant CAGR during the forecast period. The Pap test and the HPV test are used to screen the cervix for cervical cancer. A Pap test checks the cervix for abnormal cells since these abnormal cells can turn into cervical cancer in most of the cases if they aren't treated. Additionally, in some cases, cervix cells may also be tested for infection from a virus called the human papillomavirus or HPV. HPV causes most cervical cancer as well as genital warts.

The major factor that is contributing to the increasing market of HPV testing and Pap test include the increasing awareness regarding cervical cancer screening programs across the globe. Additionally, government and non-government funding and various initiatives will also drive the global HPV testing and Pap test market. For instance, since the National Health Service (NHS) cervical screening program in UK was introduced, it's gone on to save an estimated 5,000 lives each year. 

Besides, Jo's Cervical Cancer Trust is also a charity in UK that is dedicated to women affected by cervical cancer and abnormalities. However, the high cost associated with the screening will restrict the growth of HPV testing and Pap test market considerably in developing economies. In addition to this, the HPV vaccine coupled with changing regularity guidelines for the cancer screening will present as a challenge to the growth of HPV testing and Pap test market during the forecast period. 

Segmental Outlook 

The HPV testing and Pap test market is segmented based on test type and application. Based on the test type, the market is sub-segmented into the HPV test, Pap test, and Co-testing. Researchers across the globe are conducting collaborative studies for discovering the advantages of combining the HPV and Pap tests for the early diagnosis reproductive tract cancer in women. This in tur, tend to drive the global HPV testing and Pap test market during the forecast period.

Global HPV Testing and Pap Test Market Share by Test Type, 2018 (%)

Pap Test to Contribute a Prominent Share

Pap test segment is anticipated to hold a significant share in the market owing to increasing demand for effective screening solutions for cervical cancer across the globe. The primary objective of the pap test was to identify precancerous that can lead to cancer if not treated on time. Further, the high share of the segment is attributed to the high efficiency of Pap test as compared to other tests. Further, HPV testing is estimated to exhibit a lucrative CAGR during the forecast period.

Regional Outlooks

The global HPV testing and Pap test market is further segmented based on geography into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to hold the largest market share in the HPV testing and Pap test during the forecast period. The growth of the region is attributed to the increasing number of cervical cancer cases. In addition, the rising awareness among women owing to the several initiatives taken by the government tend to drive the segmental growth of the market.

Global HPV Testing and Pap Test Market Growth by Region, 2019-2025

Asia-Pacific will Augment with the Fastest Growth Rate in the HPV Testing and Pap Test Market 

Asia-Pacific is anticipated to exhibit the fastest growth rate in the HPV testing and Pap test market due to the increasing cases of cancer across the region, which in turn, increase the screening using HPV testing and Pap test. Moreover, as per Glob can, Cervical cancer is the second most common cancer among Indian women hence, initiatives by the government of India towards universalizing national level screening programs will also drive the HPV testing and Pap test market. Additionally, the rapid development of the healthcare sector is also driving the adoption of HPV testing and Pap test across the region. 

Market Players Outlook

Some of the key players of the HPV testing and Pap test market include Abbott Laboratories Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Co., Qiagen NV, Quest Diagnostics Inc., Quest Diagnostics Inc., Seegene, Inc., TAKARA SHUZO Co., Ltd., and others. The market players are considerably contributing to the market growth by adopting various strategies including new product launch, merger, and acquisition, collaborations to stay competitive in the market.

The Report Covers

• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global HPV testing and Pap test market. Based on the availability of data, information related to products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.